New Issue: Barclays sells $550,000 phoenix autocallable notes on Moderna

By Wendy Van Sickle

Columbus, Ohio, Jan. 14 – Barclays Bank plc priced $550,000 of phoenix autocallable notes due Jan. 11, 2022 linked to the common stock of Moderna, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 24.25% if the stock closes at or above its 50% coupon barrier on a related observation date.

The notes will be called at par plus the contingent coupon if the stock closes at or above its initial level on any quarterly call observation date other than the final one.

The payout at maturity will be par plus the coupon unless the stock finishes below 50% of its initial value, in which case investors will be fully exposed to the stock’s decline.

Barclays is the agent.

Issuer:	Barclays Bank plc
Issue:	Phoenix autocallable notes
Underlying stock:	Moderna, Inc.
Amount:	$550,000
Maturity:	Jan. 11, 2022
Coupon:	24.25% annualized, payable quarterly if stock closes at or above coupon barrier on related observation date
Price:	Par
Payout at maturity:	Par plus coupon unless stock finishes below final barrier level, in which case full exposure to stock’s decline
Call:	At par plus contingent coupon if stock closes at or above its initial level on any quarterly call observation date
Initial level:	$109.18
Coupon barrier:	$54.59, 50% of initial level
Final barrier:	$54.59, 50% of initial level
Pricing date:	Jan. 6
Settlement date:	Jan. 8
Agent:	Barclays
Fees:	1.1%
Cusip:	06747QVT1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.